| __timestamp | Alpine Immune Sciences, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 31354781 |
| Thursday, January 1, 2015 | 16054000 | 43445817 |
| Friday, January 1, 2016 | 23316000 | 66489820 |
| Sunday, January 1, 2017 | 10626000 | 96886134 |
| Monday, January 1, 2018 | 28970000 | 153793000 |
| Tuesday, January 1, 2019 | 35847000 | 148369000 |
| Wednesday, January 1, 2020 | 27185000 | 151934000 |
| Friday, January 1, 2021 | 58742000 | 198532000 |
| Saturday, January 1, 2022 | 70243000 | 112128000 |
| Sunday, January 1, 2023 | 80904000 | 76192000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) investments are crucial for driving innovation and growth. Over the past decade, TG Therapeutics, Inc. and Alpine Immune Sciences, Inc. have demonstrated significant commitment to R&D, with notable trends in their financial strategies.
From 2014 to 2023, TG Therapeutics consistently increased its R&D spending, peaking in 2021 with an investment nearly six times that of 2014. This upward trend underscores the company's dedication to advancing its therapeutic pipeline, particularly in the field of oncology.
Alpine Immune Sciences also showed a robust increase in R&D investments, with a remarkable 560% growth from 2014 to 2023. This surge highlights the company's focus on developing innovative immune therapies.
Both companies exemplify the biotech industry's relentless pursuit of groundbreaking treatments, with R&D at the heart of their strategies.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Alpine Immune Sciences, Inc.
R&D Insights: How AstraZeneca PLC and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Takeda Pharmaceutical Company Limited and Alpine Immune Sciences, Inc. Allocate Funds
R&D Insights: How Neurocrine Biosciences, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Viatris Inc. and Alpine Immune Sciences, Inc.
Exelixis, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Halozyme Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Madrigal Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Verona Pharma plc
Comparing Innovation Spending: TG Therapeutics, Inc. and PTC Therapeutics, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.